Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy. Double- Blind, Randomized, Controlled Clinical Trial
Sponsor: Coordinación de Investigación en Salud, Mexico
Terminated
erminated \[The study was withdrawn because of the reconversion of the hospital to care for patients with COVID19. For this reason, it was not possible to continue recruiting and monitoring patients for this clinical study.\]
Other terminated trials from Coordinación de Investigación en Salud, Mexico
- Obesity · Phase NA · Mar 2025
- Head and Neck Squamous Cell Carcinoma · Phase NA · Jul 2021
- Liver Cirrhosis · Phase NA · Jul 2021
- Liver Cirrhosis · Phase NA · Jul 2021
- Premature Birth · Phase PHASE3 · Jul 2016
See all terminations from Coordinación de Investigación en Salud, Mexico
Other Hepatic Encephalopathy trials with similar outcome
This NA trial investigates Hepatic Encephalopathy and Liver Cirrhosis and is currently terminated or withdrawn. Coordinación de Investigación en Salud, Mexico leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Mar 2023 — Jul 2024 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Jan 2021 — Mar 2023 [monthly]
Suspended NA
▶ Show 3 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Suspended NA
-
Jun 2018 — Aug 2020 [monthly]
Suspended NA
-
Jan 2017 — Jun 2018 [monthly]
Suspended NA
First recorded
Jul 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Coordinación de Investigación en Salud, Mexico
For direct contact, visit the study record on ClinicalTrials.gov .